SCHEMBL23699440

SCHEMBL23699440

CN(CC(Cc1cccc(C#N)c1)C(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.56
MAOB P27338 1/20 0.43
SLC7A5 Q01650 1/20 0.41
CTSS P25774 4/20 0.39
CTSK P43235 3/20 0.39
CTSB P07858 3/20 0.39
CTSL P07711 2/20 0.39
PTGES O14684 1/20 0.39
NLRP3 Q96P20 1/20 0.38
FFAR1 O14842 2/20 0.38
FFAR4 Q5NUL3 1/20 0.38
GLA P06280 1/20 0.38
MEP1A Q16819 1/20 0.37
MEP1B Q16820 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ABCB1 P08183 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23699431 0.86 MAOB (0.42) FOLH1MAOBCTSSCTSKCTSB
SCHEMBL23699429 0.84 CYP1A2 (0.51) FOLH1SLC6A4
SCHEMBL23699358 0.83 CTSS (0.47) FOLH1MAOBSLC7A5CTSSCTSK
SCHEMBL25182974 0.82 FOLH1 (0.49) FOLH1MAOBSLC7A5CTSSCTSK
SCHEMBL23699341 0.82 PPARA (0.45) FOLH1MAOBSLC7A5
SCHEMBL1915526 0.82 FOLH1 (0.60) FOLH1MAOBSLC7A5CTSSCTSK
SCHEMBL1915530 0.82 FOLH1 (0.60) FOLH1MAOBSLC7A5CTSSCTSK
SCHEMBL320434 0.81 MEP1A (0.49) FOLH1MAOBCTSSCTSBCTSL
SCHEMBL23699405 0.79 MAOB (0.41) MAOBCTSSCTSKCTSBCTSL
SCHEMBL25956546 0.78 FOLH1 (0.47) FOLH1MAOBSLC7A5PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed
EP-3858439-A1 AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2021-08-04 EP disclosed